InnovAge Financial Statements
NASDAQ: INNVHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
InnovAge revenue and earnings
In fiscal 2026, InnovAge generated $989.7 million in revenue, up 15.9% from fiscal 2025, its 3rd consecutive year of revenue growth. InnovAge reported a net loss of $2.5 million, compared with a loss of $30.3 million a year earlier. Gross margin was 23.0% (up from 18.0%) and operating margin 0.3%.
Diluted earnings per share came in at -$0.02. Over the last 5 fiscal years, INNV's revenue has grown at a 9.2% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
InnovAge income statement (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 |
|---|---|---|---|---|---|---|---|
| Revenue | 989.71M | 853.70M | 763.86M | 688.09M | 698.64M | 637.80M | 567.19M |
| Revenue growth (YoY) | +15.93% | +11.76% | +11.01% | -1.51% | +9.54% | +12.45% | — |
| Gross Profit | 227.76M | 153.64M | 132.06M | 101.29M | 135.37M | — | — |
| Operating Expenses | 225.15M | 183.40M | 155.24M | 150.68M | 139.78M | — | — |
| Selling, General & Admin | 200.85M | 150.28M | 136.29M | 135.26M | 125.85M | 154.57M | 77.48M |
| Operating Income | 2.62M | -29.76M | -23.18M | -49.40M | -4.41M | -12.34M | 50.93M |
| Interest Expense | — | — | — | — | 2.53M | 16.79M | 14.62M |
| Other Income (Expense) | -2.35M | -4.27M | 1.36M | -1.40M | -2.83M | -22.63M | -15.30M |
| Pretax Income | 266.00K | -34.03M | — | — | — | — | — |
| Income Tax | 949.00K | 1.32M | 1.40M | -7.24M | 723.00K | 9.77M | 9.87M |
| Net Income | -2.54M | -30.31M | -21.34M | -40.67M | -6.52M | -43.99M | 26.28M |
| Net Income growth (YoY) | — | — | — | — | — | -267.39% | — |
| EPS (Basic) | -0.02 | -0.22 | -0.16 | -0.30 | -0.05 | -0.36 | 0.20 |
| EPS (Diluted) | -0.02 | -0.22 | -0.16 | -0.30 | -0.05 | -0.36 | 0.19 |
| Shares Outstanding (Basic) | 135.70M | 135.39M | 135.90M | 135.59M | 135.52M | 123.62M | 132.62M |
| Shares Outstanding (Diluted) | 135.70M | 135.39M | 135.90M | 135.59M | 135.52M | 123.62M | 135.23M |
| EBITDA | 23.76M | -10.25M | -4.23M | -33.98M | 9.52M | -43.00K | 62.22M |
| Gross Margin | 23.01% | 18.00% | 17.29% | 14.72% | 19.38% | — | — |
| Operating Margin | 26.00% | -3.49% | -3.03% | -7.18% | -63.00% | -1.93% | 8.98% |
| Net Margin | -26.00% | -3.55% | -2.79% | -5.91% | -93.00% | -6.90% | 4.63% |
This table shows 7 annual periods of InnovAge's income statement, from FY 2026 back to FY 2020, across 18 line items including revenue, gross profit, operating expenses. Values in USD; B = billions, M = millions. Fiscal periods follow INNV's reporting calendar. What is a income statement?